Morsy, K. H., Zaghloul, A. and Mahmoud, M. (2016) “Can eicosapentaenoic acid maintain the original ribavirin dose or affect the response during the treatment course of chronic hepatitis C virus (HCV) patients?”, Turkish Journal of Gastroenterology, 27(1), pp. 55–61. doi: 10.5152/tjg.2015.150280.